Everything below concerns thymosin beta-4. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-12-11. Numbers and descriptions here follow the published literature rather than marketing material.
Identity and purity are checked with chromatographic and mass spectrometric methods. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities, while mass spectrometry confirms the expected molecular mass. A certificate of analysis may report a purity percentage, but the laboratory should still verify the material independently. Common quality concerns include truncated sequences, deamidation, oxidation, and residual solvents from synthesis. Because TB-500 is short, some impurities can differ from the target by only a few mass units.
Reconstitution practices affect downstream measurements. The dry powder is typically dissolved in sterile water or a suitable aqueous buffer, then mixed gently rather than vortexed at high speed. Visible particles or cloudiness suggest incomplete dissolution or contamination and should be investigated. For long-term storage, aliquots should be labeled with concentration, solvent, and date. Open questions include how different buffers alter peptide conformation and whether specific container materials adsorb the peptide. Those variables can change apparent concentration in assays even when the chemical identity is correct.
Material sold under this label typically arrives as a freeze-dried powder in a sealed vial with a certificate of analysis. Such certificates usually report reversed-phase chromatography purity plus a mass confirmation, and stated purities commonly sit between 95 and 99 percent. Counter-ion identity, residual trifluoroacetate, water content, and peptide net weight are separate specifications that a certificate may or may not include. A purity figure alone does not establish sequence identity, so independent mass verification remains the practical check.
The designation TB-500 circulates in laboratory and catalog contexts without a single agreed definition. Most product listings apply it to an N-terminally acetylated seven-residue fragment of thymosin beta-4, while other listings attach the same label to the full 43-residue protein. Because the term is commercial rather than systematic, two entries bearing identical names may describe different molecules. Any documentation should therefore state which sequence a given sample is claimed to contain.
The fragment most often associated with the name carries the sequence Ac-LKKTETQ, matching residues 17 through 23 of thymosin beta-4. That region holds the actin-binding motif responsible for much of the parent protein's biochemical activity. Apart from N-terminal acetylation the peptide is unmodified and contains no disulfide bonds, so it shows little ordered secondary structure in solution. Full-length thymosin beta-4 is instead a 43-residue polypeptide of roughly 4.9 kDa found widely across mammalian cell types.
| Property | Value | Notes |
|---|---|---|
| Storage temperature (dry) | -20 °C | Protected from light and moisture |
| Storage temperature (solution) | -80 °C | Single-use aliquots recommended |
| Identity assay | LC-MS or MALDI-TOF | Confirms mass near 889 Da |
| Purity assay | RP-HPLC | Reports main peak percentage |
| Common impurities | Truncated peptides, deamidated forms | Arise from synthesis or storage |
Purity is normally assessed by reversed-phase HPLC, with the main peak reported as a percentage of total peak area, while identity is confirmed by mass spectrometry. Electrospray and MALDI-TOF instruments are both used, and the observed mass is compared with the value calculated from the stated sequence. Ion-exchange or size-exclusion methods appear where aggregation or charge variants are of interest. Water content, counter-ion content and residual trifluoroacetate from purification are separate variables that can shift the measured mass and should be weighed when reading a certificate of analysis.
Research peptides are typically supplied as a white to off-white lyophilised powder in a sealed vial. The dry solid is more stable than a solution and is normally kept refrigerated or frozen until use. Dissolution is usually done in water, phosphate-buffered saline or a similar aqueous medium, depending on the assay. Because the material is hygroscopic and easily contaminated, opening vials in a low-humidity environment and recording the lot number before use are standard laboratory practices.
TB-500 is a shorthand label used in supplier catalogs and online discussion for a short synthetic peptide described as a fragment of thymosin beta-4. Most product listings present it as the N-terminally acetylated heptapeptide Ac-LKKTETQ, a sequence corresponding to the actin-binding region of the parent protein. The name is not a formal chemical designation and does not appear in standard nomenclature systems. Because labeling practices vary between vendors, two products sold under the same name may not contain the same molecule, and the stated sequence should be treated as a claim rather than a fixed definition.
Thymosin beta-4 is a naturally occurring protein of 43 amino acids found in most mammalian cells, where it binds actin monomers and influences filament dynamics. It was first isolated from thymus tissue in the early 1980s, and its actin-binding activity was later mapped to a short region near the N-terminus. The synthetic fragment sold as TB-500 was designed to reproduce that region rather than the full protein. Whether a short fragment reproduces the behavior of the intact molecule remains an open question, since the parent protein carries additional structural elements outside the binding region.
Published research on the intact protein is substantial, covering actin regulation, cell migration, and wound models. Research using the heptapeptide fragment specifically is far smaller, and much of the circulating material originates in supplier documentation rather than peer-reviewed reports. Where fragment studies do exist, they often employ different sequences, chain lengths, or terminal modifications, which complicates direct comparison across papers. Readers encountering claims about TB-500 should therefore separate evidence about thymosin beta-4 from evidence about the fragment itself.
The preparation of other cuprates is more difficult than the YBCO preparation. They also have a different crystal structure: they are tetragonal where YBCO is orthorhombic. Problems in these superconductors arise because of the existence of three or more phases having a similar layered structure. Moreover, the crystal structure of other tested cuprate superconductors are very similar. Like YBCO, the perovskite-type feature and the presence of simple copper oxide (CuO2) layers also exist in these superconductors. However, unlike YBCO, Cu–O chains are not present in these superconductors. The YBCO superconductor has an orthorhombic structure, whereas the other high-Tc superconductors have a tetragonal structure. There are three main classes of superconducting cuprates: bismuth-based, thallium-based and mercury-based. The second cuprate by practical importance is currently BSCCO, a compound of Bi–Sr–Ca–Cu–O. The content of bismuth and strontium creates some chemical issues. It has three superconducting phases forming a homologous series as Bi2Sr2Can−1CunO4+2n+x (n=1, 2 and 3). These three phases are Bi-2201, Bi-2212 and Bi-2223, having transition temperatures of 20 K (−253.2 °C), 85 K (−188.2 °C) and 110 K (−163 °C), respectively, where the numbering system represent number of atoms for Bi Sr, Ca and Cu respectively. The two phases have a tetragonal structure which consists of two sheared crystallographic unit cells.
=== Action on the cell === After insulin enters the bloodstream, it binds to a membrane-spanning receptor tyrosine kinase (RTK). This glycoprotein is embedded in the cellular membrane and has an extracellular receptor domain, made up of two α-subunits, and an intracellular catalytic domain made up of two β-subunits. The α-subunits act as insulin receptors and the insulin molecule acts as a ligand. Together, they form a receptor-ligand complex. Binding of insulin to the α-subunit results in a conformational change of the protein, which activates tyrosine kinase domains on each β-subunit. The tyrosine kinase activity causes an autophosphorylation of several tyrosine residues in the β-subunit. The phosphorylation of 3 residues of tyrosine is necessary for the amplification of the kinase activity. This autophosphorylation triggers the activation of the docking proteins, in this case IRS (1-4) on which phosphatidylinositol-3-Kinase (PI-3K) can be attached or GRB2 where the ras guanine nucleotide exchange factor (GEF) (also known as SOS) can be attached. PI-3K causes the phosphorylation of PIP2 to PIP3. This phospholipid acts as a docking site for PDPK1 and AKT2, which is then phosphorylated by the latter and PK2 to be activated. This leads to crucial metabolic functions such as synthesis of lipids, proteins, and glycogen. It also leads to cell survival and cell proliferation. Most importantly, the PI-3K pathway is responsible for the distribution of glucose for important cell functions.
The major metabolite of progesterone in the urine is the 3α,5β,20α isomer of pregnanediol glucuronide, which has been found to constitute 15–30% of an injection of progesterone. Other metabolites of progesterone formed by the enzymes in this pathway include 3α-dihydroprogesterone, 3β-dihydroprogesterone, 20α-dihydroprogesterone, and 20β-dihydroprogesterone, as well as various combination products of the enzymes aside from those already mentioned. Progesterone can also first be hydroxylated (see below) and then reduced. Endogenous progesterone is metabolized approximately 50% into 5α-dihydroprogesterone in the corpus luteum, 35% into 3β-dihydroprogesterone in the liver, and 10% into 20α-dihydroprogesterone. Relatively small portions of progesterone are hydroxylated via 17α-hydroxylase (CYP17A1) and 21-hydroxylase (CYP21A2), into 17α-hydroxyprogesterone and 11-deoxycorticosterone (21-hydroxyprogesterone), respectively, and pregnanetriols are formed secondarily to 17α-hydroxylation. Even smaller amounts of progesterone may also be hydroxylated via 11β-hydroxylase (CYP11B1) and, to a lesser extent, via aldosterone synthase (CYP11B2) into 11β-hydroxyprogesterone. In addition, progesterone can be hydroxylated in the liver by other cytochrome P450 enzymes that are not steroid-specific. Catalyzed mainly by CYP3A4, 6β-Hydroxylation is the major transformation and is responsible for approximately 70% of cytochrome P450-mediated progesterone metabolism. Other routes include 6α-, 16α-, and 16β-hydroxylation.
The stability of an emulsion, like a suspension, can be studied in terms of zeta potential, which indicates the repulsion between droplets or particles. If the size and dispersion of droplets does not change over time, it is said to be stable. For example, oil-in-water emulsions containing mono- and diglycerides and milk protein as surfactant showed that stable oil droplet size over 28 days storage at 25 °C.
radians) electric sector, a drift length which is followed by a 90° magnetic sector of opposite curvature direction. The entry of the ions sorted primarily by charge into the magnetic field produces an energy focussing effect and much higher transmission than a standard energy filter. This geometry is often used in applications with a high energy spread in the ions produced where sensitivity is nonetheless required, such as spark source mass spectrometry (SSMS) and secondary ion mass spectrometry (SIMS). The advantage of this geometry over the Nier–Johnson geometry is that the ions of different masses are all focused onto the same flat plane. This allows the use of a photographic plate or other flat detector array.
Sources: en.wikipedia.org
To promote weight gain and muscle growth As an adjunct in the treatment of bone pain and decreased bone strength associated with osteoporosis As an adjunct for catabolic states such as corticosteroid therapy and convalescence as in chronic infections, extensive surgery, and severe trauma To treat treatment-refractory anemias (via stimulation of erythropoiesis) such as acquired and congenital aplastic anemia and anemia of chronic kidney disease As an adjunct to improve strength and well-being in arthritis To treat short stature in youth
There are no definite historical records concerning the particular shroud currently at Turin Cathedral prior to the 14th century. A burial cloth, which some historians maintain was the Shroud, was owned by the Byzantine emperors but disappeared during the Sack of Constantinople in 1204. Although there are numerous reports of Jesus's burial shroud, or an image of his head, of unknown origin, being venerated in various locations before the 14th century, there is no historical evidence that these refer to the shroud currently in Turin. In 1353 the village of Lirey, in north-central France, was enriched with a small collegiate church endowed by the local feudal lord, a knight named Geoffroi de Charny. Charny died in 1356 at the Battle of Poitiers. Around 1355, the dean of the chapter of Lirey, Robert de Caillac, began exhibiting in the church a long fabric that bore an image of the mangled body of Jesus. Nicole Oresme, the Bishop of Lisieux, denounced the shroud as a forgery, believing it to be the work of clergymen for the purpose of making money for their churches. In 1390 the Bishop of Troyes, Pierre d'Arcis, who had jurisdiction over the church in Lirey, wrote a lengthy memorandum to Antipope Clement VII (recognized as Pope by the Church in France during the Western Schism), declaring that the Shroud was a forgery and that a previous Bishop of Troyes, Henri de Poitiers, had identified the artist who had made it.
=== Research and safety === G. biloba and its extracts are not approved drugs in the United States and do not have sufficient clinical evidence for uses as a therapy, according to a 2023 review. The United States National Center for Complementary and Integrative Health concludes that, despite extensive research, ginkgo has never been conclusively proven effective for any health condition, including dementia, cognitive decline, or other disorders for which it is commonly marketed. Although extracts of G. biloba leaf are often marketed to consumers as cognitive enhancers, there is no high-quality, peer-reviewed evidence supporting its use for memory or attention improvement in healthy people, as of February 2026. Systematic reviews have found no evidence for effectiveness of ginkgo extract in treating high blood pressure, menopause-related cognitive dysfunction, tinnitus, post-stroke recovery, or altitude sickness. A 2026 Cochrane review found that G. biloba shows little to no meaningful benefit for mild cognitive impairment or subjective complaints, uncertain or minimal effects in multiple sclerosis-related cognitive issues, and small to moderate, low-certainty improvements in dementia symptoms, with generally similar safety to placebo. Although a 2021 umbrella review concluded that G. biloba may be useful and safe for improving cognitive function and daily living activities in people with Alzheimer's disease, a 2023 analysis concluded there is insufficient evidence to support its use in Alzheimer's therapy. A 2016 systematic review concluded that G.
=== Radar cross-section (RCS-)reducing metamaterials === Metamaterials have applications in stealth technology, which reduces RCS in any of various ways (e.g., absorption, diffusion, redirection). Conventionally, the RCS has been reduced either by radar-absorbent material (RAM) or by purpose shaping of the targets such that the scattered energy can be redirected away from the source. While RAMs have narrow frequency band functionality, purpose shaping limits the aerodynamic performance of the target. More recently, metamaterials or metasurfaces have been synthesized that can redirect the scattered energy away from the source using either array theory or generalized Snell's law. This has led to aerodynamically favorable shapes for the targets with the reduced RCS.
=== 26 February === Food aid was halted due to continued attacks on the Zamzam camp. Russia called on the UN to support the Sudanese government's peace efforts and warned against the parallel RSF government that could halt efforts to support stability in Sudan.
Sources: en.wikipedia.org
== Properties == The boiling point of H2O2 has been extrapolated as being 150.2 °C (302.4 °F), approximately 50 °C (90 °F) higher than water. In practice, hydrogen peroxide will undergo potentially explosive thermal decomposition if heated to this temperature. It may be safely distilled at lower temperatures under reduced pressure. Hydrogen peroxide forms stable adducts with urea (hydrogen peroxide–urea), sodium carbonate (sodium percarbonate) and other compounds. Stable hydrogen-bonded adducts with various amine oxides and substituted phosphine oxides are known. The adduct with triphenylphosphine oxide can serve as a "carrier" for H2O2 in some reactions, although triphenylphosphine oxide can also catalyze the decomposition of hydrogen peroxide.
=== Supply Chain Magazines === In September 2022, ISCEA Indonesia released Supply Chain Insights, a virtual magazine intended to share information and knowledge among Indonesian supply chain professionals. In April 2024, the Global "Sustainable Supply Chain" Magazine was released with Ushasi Segupta as Editor in Chief and Madison DeSilva as Publisher. In 2025, Dr. Mahmoud Mansi, an award-winning author of 9 books and Advisory Board Member at ISCEA, was appointed Editor in Chief of ISCEA's "Supply Chain Journal Middle East".
=== 2019 recall of Ranitidine products === In 2019, Dr. Reddy's recalled all ranitidine products in the US market due to contamination with the carcinogen N-nitrosodimethylamine (NDMA). Months later, all brands of ranitidine were recalled and it was taken off the US market, as the carcinogen was an unavoidable byproduct.
GSK plc (an abbreviation of its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England. GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500. The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK . The company developed the first malaria vaccine, RTS,S, which it said in 2014, it would make available for five per cent above cost. Legacy products developed at GSK include several listed in the World Health Organization's List of Essential Medicines, such as amoxicillin, mercaptopurine, pyrimethamine, and zidovudine.
=== Paranthropus dietary reconstruction === Plants can be characterised by the ratio of carbon isotopes they sequester, due to alterations in the evolution of photosynthetic biochemical pathways. So-called C3 plants fix CO2 into a 3-carbon molecule and have a greater proportion of 12C, whereas C4 plants fix it into a 4-carbon molecule, and have a carbon isotope signature with higher 13C. This signature translates across trophic levels and can be used to determine the diets of people and animals. Isotopic analysis has been used to illuminate the diets of the different species of the Paranthropus genus. It was determined that P. boisei had a reduced ratio of C3:C4, meaning they likely consumed a greater proportion of grasses and sedges than trees, shrubs and temperature grasses. P. aethiopicus showed a similar trend, whereas P. robustus was a generalist, with a broader dietary niche. Furthermore, carbon isotope analysis shows that around 2.37 million years ago, hominins displayed a widespread shift to favour C4 plants.
Sources: en.wikipedia.org
The dry powder is normally kept at -20 °C, protected from light and moisture. Reconstituted solutions are often divided into aliquots and stored at -80 °C to reduce freeze-thaw damage.
Reverse-phase HPLC assesses purity, and mass spectrometry confirms molecular mass. The combination helps distinguish the target peptide from truncated or modified impurities.
Buffer composition, pH, adsorption to containers, and freeze-thaw history can all affect the amount of intact peptide in solution. These factors may change results even when the starting material is chemically correct.
Usually not, though usage overlaps. The label most often refers to a short acetylated fragment of the parent protein, while thymosin beta-4 itself is the full 43-residue molecule. Because suppliers vary, a sequence statement is needed to settle the question for any particular lot.